Results 161 to 170 of about 19,199 (236)

Harnessing Antiviral Peptides: From Molecular Mechanisms to Clinical Translation. [PDF]

Curr Res Pharmacol Drug Discov
Raj A, Sharmin S, Ahmed Z, Maha TT, Bishakha AC, Akter H, Husna A, Ripa FA, Rumi F.   +8 more
europepmc   +1 more source

Ultrashort Cationic Self-assembled Peptides/Peptidomimetic Nanomaterials [PDF]

, 2014
Gilmore, B. F., Laverty, G., McCloskey, A. P.   +2 more
core  

Synergistic anion-π interactions in peptidomimetic polyethers. [PDF]

Proc Natl Acad Sci U S A
Lee S, Shin A, Park J, Yun S, Kim M, Lee DW, Kim BS.   +6 more
europepmc   +1 more source

Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma. [PDF]

Acta Pharm Sin B
Mardhian DF, Pednekar KP, Hemdan AG, Kuninty PR, Karim SA, de Winter S, Metselaar JM, Morton JP, Prakash J.   +8 more
europepmc   +1 more source

Unlocking Enol-Ugi-Derived Conformationally Restricted Peptidomimetic Motifs. [PDF]

J Org Chem
Ramiro JL, Díaz J, G Neo A, F Marcos C.
europepmc   +1 more source

Evaluation of the Synergistic Activity of Antimicrobial Peptidomimetics or Colistin Sulphate with Conventional Antifungals Against Yeasts of Medical Importance. [PDF]

J Fungi (Basel)
Mishra SK, Kuppusamy R, Nguyen C, Doeur J, Atwal H, Attard S, Sørensen K, Lin JS, Wong EHH, Hui A, Barron AE, Kumar N, Willcox M.   +12 more
europepmc   +1 more source

Editorial: Vaccines and therapeutics utilizing new adjuvants and potential inhibitors to target emerging infectious diseases. [PDF]

Front Immunol
Kim J, Jobe O, Broadhurst MJ.
europepmc   +1 more source

Correction: Musielak et al. CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not? <i>Molecules</i> 2019, <i>24</i>, 2804. [PDF]

Molecules
Musielak B, Kocik J, Skalniak L, Magiera-Mularz K, Sala D, Czub M, Stec M, Siedlar M, Holak TA, Plewka J.   +9 more
europepmc   +1 more source

From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants. [PDF]

J Med Chem
Lemieux G, Pérez-Vargas J, Désilets A, Hassanzadeh M, Thompson CAH, Gravel-Trudeau A, Joushomme A, Ennis S, Villanueva I, Marouseau É, Fraser BJ, Champagne W, Lepage M, Niikura M, Arrowsmith CH, Jean F, Leduc R, Boudreault PL.   +17 more
europepmc   +1 more source

Rationally Designed Peptidomimetics

Proceedings of the 35th European Peptide Symposium, 2018
openaire   +1 more source